{"nct_id":"NCT02483585","title":"Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention","status":"COMPLETED","status_verified_date":"2022-10","start_date":"2015-07-20","start_date_type":"ACTUAL","primary_completion_date":"2016-07-11","primary_completion_date_type":"ACTUAL","completion_date":"2017-03-20","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["AMGN"]}